DGAP-News: Epigenomics AG / Key word(s): Annual Results 27.03.2019 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Results for Financial Year 2018 Berlin (Germany) und San Diego, CA (U.S.A.), March 27, 2019 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) today announced the financial results (according […]
Category: Press Releases
15. March 2019
Epigenomics AG: U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 15.03.2019 / 12:40 The issuer is solely responsible for the content of this announcement. Press release U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based tests Berlin (Germany) and San […]
15. March 2019
Correction of the Corporate News of March 15, 2019, 12:40 pm: Epigenomics AG: U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 15.03.2019 / 14:45 The issuer is solely responsible for the content of this announcement. Correction of the Corporate News of March 15, 2019, 12:40 pm: U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying […]
07. January 2019
Epigenomics AG Announces Positive Results from Microsimulation Model
DGAP-News: Epigenomics AG / Key word(s): Scientific publication/Miscellaneous 07.01.2019 / 07:45 The issuer is solely responsible for the content of this announcement. Epigenomics AG Announces Positive Results from Microsimulation Model Berlin (Germany) and San Diego, CA (U.S.A.), January 7, 2019 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY) today announced that a microsimulation model has been […]
20. December 2018
Epigenomics AG Announces Initiation of a Prospective Clinical Study for Liver Cancer Detection
DGAP-News: Epigenomics AG / Key word(s): Study/Miscellaneous 20.12.2018 / 15:56 The issuer is solely responsible for the content of this announcement. Epigenomics AG Announces Initiation of a Prospective Clinical Study for Liver Cancer Detection Berlin (Germany) and San Diego, CA (U.S.A.), 20 December, 2018 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY) today announced the initiation […]
19. December 2018
Centers for Medicare & Medicaid Services issue official 2019 Clinical Lab Fee Schedule including Epi proColon(R)
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 19.12.2018 / 12:59 The issuer is solely responsible for the content of this announcement. Centers for Medicare & Medicaid Services issue official 2019 Clinical Lab Fee Schedule including Epi proColon(R) Berlin (Germany) and San Diego, CA (U.S.A.), December 19, 2018 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: […]